Milestone Pharmaceuticals Inc. (MIST) Research

Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.

Market snapshot

Symbol
MIST
Price
$1.30
Day change
-0.76%
Market cap
$111.7M
P/E ratio
-2.48x
52-week range
1-3.06
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$6.00

Recent news

  • Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales

    Milestone Pharmaceuticals Inc. (NASDAQ:MIST) reported first-quarter earnings on Wednesday before the market opened. Here's a rundown of the report.

  • Why Milestone Pharma Stock Is Taking A Dive Today

    • Milestone Pharmaceuticals stock is taking a hit today. Why is MIST stock falling?

  • Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

    Milestone Pharmaceuticals Inc. (NASDAQ: MIST) will release earnings for its fourth quarter before the opening bell on Thursday, March 19.

Peer companies

  • Applied Therapeutics, Inc. (APLT)
  • Corbus Pharmaceuticals Holdings, Inc. (CRBP)
  • Cardiff Oncology, Inc. (CRDF)
  • Cybin Inc. (CYBN)
  • Elicio Therapeutics, Inc. (ELTX)
  • Innate Pharma S.A. (IPHA)
  • Molecular Partners AG (MOLN)
  • PepGen Inc. (PEPG)

Recent insider activity

  • Giles Lisa M. — A-Award (77000 shares) on 2026-06-10
  • Fischer Seth H. Z. — A-Award (77000 shares) on 2026-06-10
  • Duty Stuart — A-Award (77000 shares) on 2026-06-10
  • Wills Robert James — A-Award (77000 shares) on 2026-06-10
  • TOMSICEK MICHAEL JOHN — A-Award (77000 shares) on 2026-06-10

Open Milestone Pharmaceuticals Inc. (MIST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.